Find out more about subscribing to add all events.
The obesity epidemic has underlined the need for new treatments to aid weight loss and prevent the associated cardiometabolic sequelae of obesity. The relatively recent discovery of brown adipose tissue (BAT) in adult humans has revived interest in activating this tissue to increase energy expenditure as a novel treatment for these conditions. BAT is a thermogenic organ that generates heat to maintain body temperature in a cold environment. While BAT mass and activity are reduced in obesity, BAT is a plastic organ and activity can be increased in response to certain stimuli such as repeated cold exposure. In addition, the presence of BAT is associated with improved metabolic health and reduced incidence of cardiovascular disease. Therefore, it is important to determine how to safely increase BAT mass and thermogenesis to determine its therapeutic potential. However, our understanding of the pathways regulating human BAT remains limited, in part due to its location and the difficulty in quantifying activity in vivo. To improve our understanding of human brown adipose tissue function, we have performed a series of physiological studies in healthy volunteers using techniques such as PET imaging, microdialysis and thermal imaging. We have determined key differences in the regulation of brown adipose tissue function between species, and determined how brown adipose tissue utilises energy substrates to fuel thermogenesis. Most recently, we have undertaken hypothesis-free transcriptomics in human brown adipocytes to identify novel pathways regulating BAT function and have demonstrated their relevance in vivo. Understanding the pathways regulating cold-induced thermogenesis in humans may ultimately lead to novel therapies to enhance energy expenditure and improve metabolic function.
‘I undertook my PhD at the University of Edinburgh investigating the regulation and dysregulation of tissue glucocorticoid metabolism in human obesity in a number of integrative physiological studies. I continued my postdoctoral research and clinical training as a clinical lecturer, exploring the mechanisms of glucocorticoid action in adipose tissue. In 2013, I was awarded an MRC Clinical Scientist fellowship investigating the role of human brown adipose tissue and its regulation by glucocorticoids. In 2018, I was awarded a Scottish Senior Clinical Academic Fellowship investigating the pathways regulating human brown adipose tissue and wider cold-induced thermogenesis. I am currently Professor of Endocrinology and honorary consultant physician at the University of Edinburgh. Our lab specialises in the use of human experimental medicine studies to investigate human (patho)physiology in obesity and metabolic disease. Our current focus is on dissecting the pathways regulating energy expenditure with the goal of identifying targets amenable to therapeutic manipulation.’